Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-011084
Filing Date
2025-08-11
Accepted
2025-08-11 17:25:49
Documents
58
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q capr-20250630x10q.htm   iXBRL 10-Q 1615717
2 EX-10.3 capr-20250630xex10d3.htm EX-10.3 72310
3 EX-31.1 capr-20250630xex31d1.htm EX-31.1 10472
4 EX-31.2 capr-20250630xex31d2.htm EX-31.2 10207
5 EX-32.1 capr-20250630xex32d1.htm EX-32.1 5733
6 EX-32.2 capr-20250630xex32d2.htm EX-32.2 5721
  Complete submission text file 0001558370-25-011084.txt   6515654

Data Files

Seq Description Document Type Size
7 EX-101.SCH capr-20250630.xsd EX-101.SCH 49909
8 EX-101.CAL capr-20250630_cal.xml EX-101.CAL 40810
9 EX-101.DEF capr-20250630_def.xml EX-101.DEF 190758
10 EX-101.LAB capr-20250630_lab.xml EX-101.LAB 382838
11 EX-101.PRE capr-20250630_pre.xml EX-101.PRE 313853
61 EXTRACTED XBRL INSTANCE DOCUMENT capr-20250630x10q_htm.xml XML 955605
Mailing Address 10865 ROAD TO THE CURE SUITE 150 SAN DIEGO CA 92121
Business Address 10865 ROAD TO THE CURE SUITE 150 SAN DIEGO CA 92121 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34058 | Film No.: 251203130
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)